| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 02/11/2003 | US6518418 Which are phosphite linked; protected nucleoside monophosphite-glycoside using a phosphoramiditing agent; can use to produce nucleoside-monophosphate-glycosides |
| 02/11/2003 | US6518410 Immunosuppressive agent, anticancer agent and DNA polymerase alpha inhibitor. |
| 02/11/2003 | US6518250 Agent for preventing and curing hindrance of ischemic reperfusion |
| 02/11/2003 | US6518249 Oligosaccharide derivatives and process for producing the same |
| 02/11/2003 | US6518248 Method of treating gastric or colon cancer by administration of a sulfoquinovosylacylglycerol ester |
| 02/11/2003 | CA2419223A1 Use of perfluoroalkyl-containing metal complexes as contrast media in mr-imaging for visualization of plaques, tumours and necroses |
| 02/07/2003 | WO2002014309A1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof |
| 02/07/2003 | CA2418790A1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof |
| 02/06/2003 | WO2003010178A1 Functionalised maltosyl fluoride as glycosyl donor in the chemo-enzymatic preparation of oligo- or polysaccharides |
| 02/06/2003 | US20030027980 Process for preparing lipid ii |
| 02/06/2003 | US20030027925 Use of a 2-substituted-1,3-dioxocycloalkyl linker group to couple saccharide groups of both the O-glycoside and N-glycoside type to a polymer support in a solid phase systhesis process |
| 02/06/2003 | CA2455401A1 Functionalised maltosyl fluoride as glycosyl donor in the chemo-enzymatic preparation of oligo- or polysaccharides |
| 02/05/2003 | CN1395579A Method for synthesis of alpha-D-GA (1-3) GAL-containing oligosaccharides |
| 02/05/2003 | CN1394865A Method for extracting, separating and purifying linolenic lignan by using linseed cake |
| 02/04/2003 | US6515117 C-aryl glucoside SGLT2 inhibitors and method |
| 02/04/2003 | US6514717 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes |
| 02/04/2003 | CA2112818C Mono and bis alkylamino-anthracyclines |
| 01/30/2003 | WO2003008430A2 Porphyrin derivatives for photodynamic therapy |
| 01/30/2003 | WO2003008429A2 Solvent-free anthracycline derivatives |
| 01/30/2003 | US20030023052 Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents |
| 01/30/2003 | CA2453997A1 Porphyrin derivatives for photodynamic therapy |
| 01/30/2003 | CA2453296A1 Solvent-free anthracycline derivatives |
| 01/29/2003 | EP1279676A1 Porphyrin derivatives for photodynamic therapy |
| 01/29/2003 | EP0973787B1 Process for preparing glucose suspensions and subsequent dehydration |
| 01/29/2003 | CN1100061C Hypocrellin glycoside and its preparing process |
| 01/29/2003 | CN1099894C Vaccine composition for eliciting immune response against N-glycolylated gangliosides and its use |
| 01/28/2003 | US6512101 Branched hydrazone linkers |
| 01/28/2003 | US6512100 Chromogenic substrates of sialidase and methods of making and using the same |
| 01/28/2003 | US6512099 Roselipin derivative |
| 01/28/2003 | US6511965 Ether type lipid A 1-carboxylic acid analogs |
| 01/28/2003 | CA2253654C Novel nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor |
| 01/23/2003 | WO2003006474A2 Method for producing peracylated 1-o-glycosides |
| 01/23/2003 | WO2003006028A1 Novel immunosuppressants |
| 01/23/2003 | US20030018186 Monocyclic L-nucleosides, analogs and uses thereof |
| 01/23/2003 | US20030018070 Bisaryl compound and medicament for cancer treatment comprising the same |
| 01/23/2003 | US20030017997 Dihydroxyphenyl compounds and glucoside compounds thereof |
| 01/23/2003 | US20030017187 Termiticidal bait matrix comprising a termiticide selected such that termiticide causes death to 50-100% of termites within 24-84 days after termites begin to ingest termiticide, cellulose, water |
| 01/22/2003 | EP1276758A2 A glycopeptide and preparation thereof |
| 01/22/2003 | EP1276746A2 Process for preparing lipid ii and derivatives thereof |
| 01/16/2003 | WO2003004466A2 Dye-sulfenates for dual phototherapy |
| 01/16/2003 | WO2003004098A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 01/16/2003 | WO2003004005A1 Optimised formulation of tobramycin for aerosolization |
| 01/16/2003 | US20030013666 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 01/16/2003 | CA2452372A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 01/15/2003 | EP1274404A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents |
| 01/15/2003 | EP1165581B1 Method for the production of 4'-demethyl - 4'-phosphate-2",3" - bis pentafluorophenoxyacetyl - 4",6"-ethylidene - beta-d- glucoside epipodophyllotoxin and the salts thereof |
| 01/15/2003 | EP1020475B1 Method of purifying daunomycin |
| 01/15/2003 | CN1390846A Aminoglycopeptide compounds with antivirus and anticanser activity |
| 01/15/2003 | CN1098860C Process for separating and concentrating high-quality stevioside |
| 01/14/2003 | US6506734 20(S) camptothecin glycoconjugates |
| 01/09/2003 | WO2003002586A1 [4-(4-cyanobenzoyl)phenyl]glycofuranoside derivatives, use of said derivatives as a medicament, production method thereof and pharmaceutical compositions containing same |
| 01/09/2003 | WO2003002585A1 [4-(4-cyanobenzoyl)phenyl]glycopyranoside derivatives, use of same as a medicament, production method thereof and compositions |
| 01/09/2003 | WO2003002584A1 NOVEL GALACTOSYLCERAMIDE ANALOGS AND β-GLUCOCEREBROSIDASE ACTIVATORS, EXTERNAL SKIN PREPARATIONS AND METHOD OF ACTIVATING β-GLUCOCEREBROSIDASE USING THE ANALOGS |
| 01/09/2003 | WO2003002563A1 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives |
| 01/09/2003 | WO2003002127A1 Use of at least one glycoinhibitor substance |
| 01/09/2003 | WO2003002066A2 Glycosylated kinamycins and methods of making and using them |
| 01/09/2003 | CA2452192A1 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives |
| 01/08/2003 | EP1273292A1 Optimised formulation of tobramycin for aerosolization |
| 01/08/2003 | EP1272499A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 01/08/2003 | EP0859768B1 Amine acid salt compounds and process for the production thereof |
| 01/08/2003 | CN1390204A Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/08/2003 | CN1098106C Anthracycline conjugates, their preparation and their use as antitumor agents |
| 01/07/2003 | US6504018 Process for preparing pale-colored and transparent alkyl glycosides |
| 01/07/2003 | US6503885 Carboxymethylgalactose derivatives |
| 01/07/2003 | US6503880 Cationic sugar surfactants from ethoxylated ammonium compounds and reducing saccharides |
| 01/07/2003 | CA2192481C Drug salts |
| 01/07/2003 | CA2089666C Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/03/2003 | WO2003000922A2 Chimeric immunomodulatory compounds and methods of using the same |
| 01/03/2003 | WO2003000711A1 Antimitotic eleuthesides |
| 01/03/2003 | WO2003000710A1 Alkyl- and/or alkenyloligoglycoside preparations having reduced magnesium salt concentrations |
| 01/03/2003 | WO2003000709A2 Sialic acid derivatives for use as siglec inhibitors |
| 01/03/2003 | WO2002060911A3 C-glucosyl ether lipids |
| 01/03/2003 | WO2002048163A3 PROCESSES FOR THE PREPARATION OF αGAL(1→4)βGAL(1→4)GLC-OR TRISACCHARIDES |
| 01/03/2003 | WO2002018405A3 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives |
| 01/03/2003 | CA2451974A1 Chimeric immunomodulatory compounds and methods of using the same |
| 01/03/2003 | CA2451511A1 Antimitotic eleuthesides |
| 01/02/2003 | US20030004322 Antiinflammatory agents; immobilized on solid support |
| 01/02/2003 | US20030004321 Glycosylated analogs of fusidic acid |
| 01/02/2003 | EP1270584A1 Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives |
| 01/02/2003 | EP1268505A2 Solid phase synthesis method and reagent |
| 01/02/2003 | EP1268503A1 O-glucosylated benzamide sglt2 inhibitors and method |
| 01/02/2003 | EP1268502A1 O-aryl glucoside sglt2 inhibitors and method |
| 01/02/2003 | EP1268453A1 Estrogen agonist/antagonist metabolites |
| 01/02/2003 | EP1268052A2 High throughput screening array containing porous material |
| 01/02/2003 | EP0989989B1 13-dihydro-3'aziridino anthracyclines |
| 01/02/2003 | EP0877618B1 Antifungal agent |
| 12/31/2002 | US6500936 Glycerol culture of actinomyces |
| 12/30/2002 | WO2002002582A1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same |
| 12/30/2002 | CA2414605A1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same |
| 12/27/2002 | WO2002103025A1 Novel sulfated saccharide and process for producing the same |
| 12/27/2002 | WO2002102817A1 Anti-tumour anthracycline glycoside 14-sulfonic acid derivatives |
| 12/27/2002 | WO2002102816A1 Method for producing perbenzylated 1-o-glycosides |
| 12/27/2002 | WO2002102416A2 Antiviral glycoconjugates |
| 12/27/2002 | WO2002102325A2 Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein c |
| 12/27/2002 | CA2447624A1 Anti-tumour compound |
| 12/26/2002 | US20020198437 Method of manufacturing a soft hearing aid |
| 12/26/2002 | US20020198157 Galectins-carbohydrate conjugate complexes with required photophysical properties to damage cancer cells |
| 12/26/2002 | US20020198141 Molecular conjugates for use in treatment of cancer |
| 12/26/2002 | US20020197683 Metabolic controlled fermentation process for carbamoyl tobramycin production |
| 12/26/2002 | US20020197675 Glial nerovus system modulator for use in the treatment of nervous system disorders and spine damage |